Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)
NCT00380705
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
91
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Rhinitis Allergic
Interventions
DRUG:
MK0476, Singulair, montelukast sodium / Duration of Treatment: 8 Weeks
Sponsor
Organon and Co